Cell differentiation and iodine-131 uptake in poorly differentiated thyroid tumour in response to nevirapine.
Landriscina
Matteo
M
Clinical Oncology Unit, Department of Medical Sciences, University of Foggia, Foggia, Italy. m.landriscina@unifg.it
Modoni
Sergio
S
Fabiano
Annarita
A
Fersini
Alberto
A
Barone
Carlo
C
Ambrosi
Antonio
A
Cignarelli
Mauro
M
D000368:Aged; D002291:Carcinoma, Papillary / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D002454:Cell Differentiation / Q000187:drug effects*; D002478:Cells, Cultured; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007457:Iodine Radioisotopes / Q000493:pharmacokinetics / Q000627:therapeutic use; D019829:Nevirapine / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D013954:Thyroglobulin / Q000032:analysis; D013961:Thyroid Gland / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D013964:Thyroid Neoplasms / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D013965:Thyroidectomy; D014407:Tumor Cells, Cultured
D007457:Iodine Radioisotopes; D018894:Reverse Transcriptase Inhibitors; D013954:Thyroglobulin; D019829:Nevirapine